Published gastric cancer extracellular matrix prognostic signatures converge on a shared core-matrisome axis associated with molecular subtype
Extracellular matrix (ECM) gene-expression signatures are repeatedly reported as prognostic in gastric cancer, yet seldom re-evaluated against a simple matrisome reference. We re-scored all nine signatures meeting prespecifi ed criteria in a structured PubMed search and our evidence-weighted score in The Cancer Genome Atlas stomach adenocarcinoma cohort (TCGA-STAD; 387 patients) and two Korean microarray cohorts, GSE84437 (431 patients) and GSE62254 (300 patients). With frozen weights, the fourteen-module score was associated with survival in both external cohorts (hazard ratio per SD, 1.27 and 1.32) but added no detectable prognostic information beyond an unweighted core-matrisome average. One component explained 70–84% of module-activity variance, with nearly identical loadings across cohorts. Published signatures correlated with the core average at median 0.71, and only one of eleven primary evaluations in cohorts independent of a signature’s development or validation added information beyond it. In GSE62254, molecular subtype explained 32% of score variance; the hazard ratio after clinical and subtype adjustment was 1.19 (95% CI 0.98–1.44). The signatures examined largely tracked one shared axis. In the cohort with molecular annotation, this axis was closely associated with mesenchymal subtype; new signatures should demonstrate added value beyond both references.
Authors
- Quang Toan Dao
- Viet Anh Nguyen
- Tri Tuyen Luc
Institutions
- Vietnam Academy of Science and Technology (VN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11531904/v1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- preprint